Congrats on the nice partial recovery of MNTA today!
I don’t deserve congratulations with respect to MNTA yet. Although I made a sizable purchase last week that was (apparently) close to the bottom (#msg-101624530), those shares aren’t going to show a meaningful profit unless the FDA approves generic Copaxone in a timely manner.
Regarding my prior gains on MNTA from holdings bought in 2007 and sold in 2013, I think in hindsight that I was more lucky than smart. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.